Scotiabank (TSX:BNS) increased its price target for INmune Bio Inc. (NASDAQ:INMB) shares to $23.00, up from the previous target of $22.00, while maintaining a Sector Outperform rating. The stock, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback